Your browser doesn't support javascript.
loading
Ramucirumab and Paclitaxel Administered Every 2 Weeks (mRAINBOW Regimen) in Advanced Gastroesophageal Adenocarcinoma.
Rogers, Jane E; Xiao, Lianchun; Amlashi, Fatemeh G; Elimova, Elena; Blum Murphy, Mariela A; Sanders, Elizabeth; Shanbhag, Namita; Thomas, Irene; Ajani, Jaffer A.
Afiliação
  • Rogers JE; Pharmacy Clinical Programs, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Xiao L; Department of Biostatistics, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Amlashi FG; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Elimova E; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Blum Murphy MA; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Sanders E; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Shanbhag N; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Thomas I; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Ajani JA; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA, jajani@mdanderson.org.
Oncology ; 96(5): 252-258, 2019.
Article em En | MEDLINE | ID: mdl-30893708
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Junção Esofagogástrica / Anticorpos Monoclonais Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Junção Esofagogástrica / Anticorpos Monoclonais Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos